VP7-2021: KEYNOTE-522: Phase III study of neoadjuvant pembrolizumab + chemotherapy vs. placebo + chemotherapy, followed by adjuvant pembrolizumab vs. placebo for early-stage TNBC
Peter Schmid, Javier Cortés, Rebecca Alexandra Dent et al. · Annals of Oncology · 2021
Cited by 135 works. doi:10.1016/j.annonc.2021.06.014 Open-access PDF
Authors
- Peter Schmid
- Javier Cortés
- Rebecca Alexandra Dent
- Lajos Pusztai
- HL McArthur
- Sherko Kümmel
- Jonas C. S. Bergh
- Carsten Denkert
- Y.H. Park
- Rina Hui
- Nadia Harbeck
- Masato Takahashi
- Michael Untch
- Peter Andreas Fasching
- Fátima Cardoso
- Yu Ding
- Konstantinos Tryfonidis
- Gursel Aktan
- Vassiliki Karantza
- Joyce O’Shaughnessy